We are live on ! Find out more
FGP

Foyston, Gordon, & Payne Portfolio holdings

AUM $434M
1-Year Est. Return 9.09%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+9.09%
3 Year Est. Return
+56.86%
5 Year Est. Return
+84.63%
10 Year Est. Return
+238.52%
AUM
$429M
AUM Growth
+$28.3M
Cap. Flow
-$14.6M
Cap. Flow %
-3.42%
Top 10 Hldgs %
44.03%
Holding
65
New
7
Increased
14
Reduced
32
Closed
4

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$7.29M
2
VMW
VMware, Inc
VMW
+$6.16M
3
GNTX icon
Gentex
GNTX
+$1.36M
4
EFX icon
Equifax
EFX
+$1.22M
5
MDLZ icon
Mondelez International
MDLZ
+$735K

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.62M
2
CSCO icon
Cisco
CSCO
+$3.77M
3
BKNG icon
Booking.com
BKNG
+$2.57M
4
RTX icon
RTX Corp
RTX
+$2.54M
5
MDT icon
Medtronic
MDT
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 25.16%
2 Healthcare 21.09%
3 Industrials 16.9%
4 Consumer Staples 11.3%
5 Financials 10.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AOS icon
26
A.O. Smith
AOS
$8.17B
$6.4M 1.49%
74,593
-6,192
-8% -$472K
OTIS icon
27
Otis Worldwide
OTIS
$27.4B
$5.86M 1.37%
67,260
-19,731
-23% -$1.65M
KO icon
28
Coca-Cola
KO
$377B
$5.55M 1.29%
93,720
SONY icon
29
Sony
SONY
$137B
$5.52M 1.29%
218,265
-9,235
-4% -$220K
PFE icon
30
Pfizer
PFE
$143B
$5.45M 1.27%
92,278
-1,719
-2% -$85.2K
VMW
31
DELISTED
VMware, Inc
VMW
$5.43M 1.27%
+46,871
New +$6.16M
ULTA icon
32
Ulta Beauty
ULTA
$22B
$5.24M 1.22%
12,696
+192
+2% +$74.6K
CPRT icon
33
Copart
CPRT
$27B
$4.95M 1.16%
130,664
-11,056
-8% -$410K
BRK.B icon
34
Berkshire Hathaway Class B
BRK.B
$1.1T
$4.88M 1.14%
16,323
ROST icon
35
Ross Stores
ROST
$80.5B
$4.82M 1.13%
42,210
+327
+0.8% +$36.6K
CTVA icon
36
Corteva
CTVA
$52.6B
$4.79M 1.12%
101,277
-35,382
-26% -$1.61M
CME icon
37
CME Group
CME
$96.3B
$4.33M 1.01%
18,938
-279
-1% -$61.4K
BDX icon
38
Becton Dickinson
BDX
$45.6B
$3.66M 0.85%
14,921
-570
-4% -$137K
ALSN icon
39
Allison Transmission
ALSN
$9.5B
$3.54M 0.83%
97,504
+651
+0.7% +$23K
VVV icon
40
Valvoline
VVV
$4.9B
$3.3M 0.77%
88,482
-21,676
-20% -$756K
AXTA icon
41
Axalta
AXTA
$7.66B
$3.08M 0.72%
92,999
-20,526
-18% -$651K
WMT icon
42
Walmart Inc
WMT
$885B
$2.89M 0.67%
59,850
NVS icon
43
Novartis
NVS
$297B
$2.77M 0.65%
31,645
-11,644
-27% -$967K
RTX icon
44
RTX Corp
RTX
$290B
$2.64M 0.62%
30,718
-29,171
-49% -$2.54M
CDW icon
45
CDW
CDW
$18.9B
$2.55M 0.6%
12,471
+620
+5% +$118K
RELX icon
46
RELX
RELX
$61.8B
$2.36M 0.55%
72,304
-5,233
-7% -$163K
SNY icon
47
Sanofi
SNY
$103B
$2.27M 0.53%
45,411
-1,950
-4% -$96.5K
TRU icon
48
TransUnion
TRU
$15.1B
$1.78M 0.42%
15,025
-14,756
-50% -$1.69M
ABT icon
49
Abbott
ABT
$183B
$1.72M 0.4%
12,200
TJX icon
50
TJX Companies
TJX
$174B
$1.67M 0.39%
22,025
-1,474
-6% -$102K

Similar funds

Foyston, Gordon, & Payne's Q4 2021 Portfolio in Review

As of Q4 2021, Foyston, Gordon, & Payne held 65 positions worth $429M, up 7.1% from $400M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Foyston, Gordon, & Payne withdrew a net $14.6M in Q4 2021, closing 4 positions and reducing 32 holdings. Its most notable exit was Starbucks, an estimated $1.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Foyston, Gordon, & Payne opened a new position in Visa worth $7.35M.

  • Foyston, Gordon, & Payne's largest Q4 2021 buy was Visa: 33,937 shares worth $7.35M.
  • Foyston, Gordon, & Payne added most to Gentex in Q4 2021, an estimated $1.36M increase.
  • Foyston, Gordon, & Payne's biggest Q4 2021 reduction was Microsoft, cutting an estimated $6.62M.
  • Foyston, Gordon, & Payne fully exited Starbucks in Q4 2021, selling an estimated $1.32M.
  • Foyston, Gordon, & Payne's ten largest holdings make up 44% of its $429M portfolio in Q4 2021.
  • Foyston, Gordon, & Payne opened 7 new positions and closed 4 in Q4 2021.
  • Foyston, Gordon, & Payne's portfolio value rose 7.1% quarter-over-quarter to $429M.

Based on Foyston, Gordon, & Payne's 13F filing for Q4 2021, filed 11 Feb 2022.